Moffitt researchers find potential new therapeutic target for treating non-small cell lung cancer

Moffitt researchers find potential new therapeutic target for treating non-small cell lung cancer Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response. Click here to read full press release. ### Among … Continue reading “Moffitt researchers find potential new therapeutic target for treating non-small cell lung cancer”

Moffitt researchers find potential new therapeutic target for treating non-small cell lung cancer

Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response.

Click here to read full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply